Cookies on this site

A new book by Professor Samantha Vanderslott of the University of Oxford, Pro-vax, is set to redefine how we think about vaccination by spotlighting a critical but often-overlooked force: pro-vaccine activism.

Professor Vanderslott, an expert in the politics of vaccination, moves beyond the usual "pro" versus "anti" vaccine debate to examine the social and political dynamics that promote vaccine acceptance. She  delves into the strategies, achievements, and challenges faced by pro-vaccine advocates, offering an inspiring and nuanced perspective on their vital contributions.

The book blends historical research, qualitative analysis, and accessible storytelling to explore how these vaccine advocates influence public attitudes, shape health policies, and inspire community action. Through this lens, Professor Vanderslott not only highlights their underappreciated efforts but also provides practical insights for healthcare professionals, public health advocates, and academics striving to build vaccine confidence.

In discussing her motivation for writing the book, Professor Vanderslott said:

“Vaccination is both a social activity on a grand scale and an experience that is very personal and individual. Add to the mix the understanding of vaccination in culture, the media, and others around us in society, and attitudes to vaccination become complex.

For a long time, the concentration has been on attitudes to vaccination by those who are in opposition (the ‘anti-vax’), neglecting the majority who are supportive. This book aims to reconsider vaccination as a phenomenon from the perspective of those who are ‘pro-vax’, who actively support and vocally promote vaccines.”

Professor Heidi Larson, Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine praised the book, stating:

“Pro-vax sheds light on the essential but often overlooked dimension of positive activism in a challenging environment. It’s a thoughtful and well-written exploration of the people and movements driving vaccine confidence.”

With its timely message and insights, Pro-vax is set to become a key resource for those working to improve vaccine uptake and foster a better understanding of the social forces that shape public health.

Similar stories

Lymph Node Research UK launches with national network of ten specialist research centres

Oxford, 16 June 2026: A new £1.7 million UK-wide research network dedicated to unlocking the role of lymph nodes in infection, immunity and inflammatory disease has launched, bringing together ten specialist centres across the country.

The UK’s childhood vaccination schedule just changed. Here’s why that’s actually reassuring

(Published on The Conversation) The UK has updated its childhood immunisation schedule. For parents who had already mapped out their child’s vaccination appointments in their heads, the announcement might have come as an unwelcome surprise.

Prof Teresa Lambe OBE delivers the University of Notre Dame 2025 Graduate School Commencement Address

Last month, Professor Teresa Lambe OBE, the Calleva Head of Vaccine Immunology and Professor of Vaccinology & Immunology at the Oxford Vaccine Group at the University of Oxford, delivered an inspiring speech at the University of Notre Dame’s Graduate School’s annual Commencement Ceremony.

Study shows urgent change needed to reduce deaths from malaria and meningitis in comatose African children

Results of two parallel studies show that one in four African children hospitalised with malaria and coma have an additional infection, and that giving antibiotics with antimalarials could help reduce death rates of comatose children.

Professor Teresa Lambe OBE elected to the Fellowship of the Academy of Medical Sciences

Professor Teresa Lambe OBE, Calleva Head of Immunology at the Oxford Vaccine Group, and Principal Investigator at the Pandemic Sciences Institute, has been elected a Fellow of the Academy of Medical Sciences, one of the most prestigious awards in the field.

More babies could die if rates of vaccination against whooping cough don’t increase

Babies and the most vulnerable are at risk of death if vaccination rates for whooping cough don't increase, according to experts at the University of Oxford.

Similar stories

Lymph Node Research UK launches with national network of ten specialist research centres

Oxford, 16 June 2026: A new £1.7 million UK-wide research network dedicated to unlocking the role of lymph nodes in infection, immunity and inflammatory disease has launched, bringing together ten specialist centres across the country.

The UK’s childhood vaccination schedule just changed. Here’s why that’s actually reassuring

(Published on The Conversation) The UK has updated its childhood immunisation schedule. For parents who had already mapped out their child’s vaccination appointments in their heads, the announcement might have come as an unwelcome surprise.

Prof Teresa Lambe OBE delivers the University of Notre Dame 2025 Graduate School Commencement Address

Last month, Professor Teresa Lambe OBE, the Calleva Head of Vaccine Immunology and Professor of Vaccinology & Immunology at the Oxford Vaccine Group at the University of Oxford, delivered an inspiring speech at the University of Notre Dame’s Graduate School’s annual Commencement Ceremony.

Study shows urgent change needed to reduce deaths from malaria and meningitis in comatose African children

Results of two parallel studies show that one in four African children hospitalised with malaria and coma have an additional infection, and that giving antibiotics with antimalarials could help reduce death rates of comatose children.

Professor Teresa Lambe OBE elected to the Fellowship of the Academy of Medical Sciences

Professor Teresa Lambe OBE, Calleva Head of Immunology at the Oxford Vaccine Group, and Principal Investigator at the Pandemic Sciences Institute, has been elected a Fellow of the Academy of Medical Sciences, one of the most prestigious awards in the field.

More babies could die if rates of vaccination against whooping cough don’t increase

Babies and the most vulnerable are at risk of death if vaccination rates for whooping cough don't increase, according to experts at the University of Oxford.